Tissue Engineering
Vascularized bone engineered from osteoblast-polyglycolic acid scaffold
Published in Drug Week, September 9th, 2005
"Repair of skeletal defects with vascularized bone grafts has many advantages over nonvascularized free grafts, but the availability of these grafts is extremely limited.
"This study was designed to determine whether new vascularized bone could be engineered by transplantation of osteoblasts around existing vascular pedicles using biodegradable, synthetic polymer as a cell delivery vehicle," scientists in South Korea report.
"Cells were isolated from the periosteum of fetal bovine humerus, and then seeded onto nonwoven multifilament, polyglycolic acid...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-09-09)
More Articles from Drug Week
- Cancer Therapy
Two additional sites initiated for phase II ADH-1 trial - Generic Drugs
U.S. FDA approves generic equivalent to topical suspension for fungal infections - HIV/AIDS Therapy
Company updates development of fixed-dose regimen of Truvada and Sustiva - Hemophilia
Data for Advate confirm safety and efficacy in hemophilia A patients - Kidney Disease
Phase III program for ferumoxytol modified in IV iron replacement therapy - Acetylcholine Receptors
Nicotinic receptors analyzed, regulatory roles defined - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
